The University of Chicago Header Logo

MELK inhibitor, novel molecular targeted therapeutics for human cancer stem cells.

MELK inhibitor, novel molecular targeted therapeutics for human cancer stem cells. Cell Cycle. 2013 Jun 01; 12(11):1655-6.

View in: PubMed